Nektar Therapeutics
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2016 | $-117.0M | $-123.4M | $6.4M |
| FY2017 | $-80.4M | $-90.1M | $9.7M |
| FY2018 | $718.2M | $704.0M | $14.2M |
| FY2019 | $-328.7M | $-355.0M | $26.3M |
| FY2020 | $-313.3M | $-320.5M | $7.3M |
| FY2021 | $-412.7M | $-427.6M | $15.0M |
| FY2022 | $-304.0M | $-309.7M | $5.7M |
| FY2023 | $-192.6M | $-193.5M | $865.0K |
| FY2024 | $-175.7M | $-177.2M | $1.5M |
| FY2025 | $-208.5M | $-208.7M | $171.0K |